Literature DB >> 28319273

Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.

Guoqin Yu1, Nan Hu1, Lemin Wang1, Chaoyu Wang1, Xiao-You Han2, Mike Humphry3, Jacques Ravel3, Christian C Abnet1, Philip R Taylor1, Alisa M Goldstein1.   

Abstract

Little is known about the link between gastric microbiota and the epidemiology of gastric cancer. In order to determine the epidemiologic and clinical relevance of gastric microbiota, we used 16 S ribosomal RNA gene sequencing analysis to characterize the composition and structure of the gastric microbial community of 80 paired samples (non-malignant and matched tumor tissues) from gastric cardia adenocarcinoma (GCA) patients in Shanxi, China. We also used PICRUSt to predict microbial functional profiles. Compared to patients without family history of upper gastrointestinal (UGI) cancer in the non-malignant gastric tissue microbiota, patients with family history of UGI cancer had higher Helicobacter pylori (Hp) relative abundance (median: 0.83 vs. 0.38, p = 0.01) and lower alpha diversity (median observed species: 51 vs. 85, p = 0.01). Patients with higher (vs. lower) tumor grade had higher Hp relative abundance (0.73 vs. 0.18, p = 0.03), lower alpha diversity (observed species, 66 vs. 89, p = 0.01), altered beta diversity (weighted UniFrac, p = 0.002) and significant alterations in relative abundance of five KEGG functional modules in non-malignant gastric tissue microbiota. Patients without metastases had higher relative abundance of Lactobacillales than patients with metastases (0.05 vs. 0.01, p = 0.04) in non-malignant gastric tissue microbiota. These associations were observed in non-malignant tissues but not in tumor tissues. In conclusion, this study showed a link of gastric microbiota to a major gastric cancer risk factor and clinical features in GCA patients from Shanxi, China. Studies with both healthy controls and gastric cardia and noncardia cancer cases across different populations are needed to further examine the association between gastric cancer and the microbiota.
© 2017 UICC.

Entities:  

Keywords:  16S rRNA gene; H. pylori; KEGG modules; gastric cancer; microbiome

Mesh:

Substances:

Year:  2017        PMID: 28319273      PMCID: PMC5839466          DOI: 10.1002/ijc.30700

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  UniFrac: an effective distance metric for microbial community comparison.

Authors:  Catherine Lozupone; Manuel E Lladser; Dan Knights; Jesse Stombaugh; Rob Knight
Journal:  ISME J       Date:  2010-09-09       Impact factor: 10.302

2.  The mathematical theory of communication. 1963.

Authors:  C E Shannon
Journal:  MD Comput       Date:  1997 Jul-Aug

3.  Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers: A Randomized Controlled Single-Blind Pilot Study.

Authors:  Hemalatha Rajkumar; Manoj Kumar; Nilita Das; S Nishanth Kumar; Hanumanth R Challa; Ravinder Nagpal
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-10-20       Impact factor: 2.457

Review 4.  The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis.

Authors:  Alexander Sheh; James G Fox
Journal:  Gut Microbes       Date:  2013-08-19

5.  Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia.

Authors:  Ines Yang; Sabrina Woltemate; M Blanca Piazuelo; Luis E Bravo; Maria Clara Yepez; Judith Romero-Gallo; Alberto G Delgado; Keith T Wilson; Richard M Peek; Pelayo Correa; Christine Josenhans; James G Fox; Sebastian Suerbaum
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

6.  Family history and the risk of gastric cancer.

Authors:  M Yaghoobi; R Bijarchi; S A Narod
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

7.  Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study.

Authors:  Roberto Flores; Jianxin Shi; Barbara Fuhrman; Xia Xu; Timothy D Veenstra; Mitchell H Gail; Pawel Gajer; Jacques Ravel; James J Goedert
Journal:  J Transl Med       Date:  2012-12-21       Impact factor: 5.531

8.  Phylogenetic diversity (PD) and biodiversity conservation: some bioinformatics challenges.

Authors:  Daniel P Faith; Andrew M Baker
Journal:  Evol Bioinform Online       Date:  2007-02-17       Impact factor: 1.625

9.  Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features.

Authors:  Guoqin Yu; Mitchell H Gail; Dario Consonni; Michele Carugno; Michael Humphrys; Angela C Pesatori; Neil E Caporaso; James J Goedert; Jacques Ravel; Maria Teresa Landi
Journal:  Genome Biol       Date:  2016-07-28       Impact factor: 13.583

10.  Bacterial overgrowth and diversification of microbiota in gastric cancer.

Authors:  Lili Wang; Jianhua Zhou; Yongning Xin; Changxin Geng; Zibin Tian; Xinjuan Yu; Quanjiang Dong
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-03       Impact factor: 2.566

View more
  13 in total

1.  Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.

Authors:  Dantong Shao; Emily Vogtmann; Anqi Liu; Junjie Qin; Wen Chen; Christian C Abnet; Wenqiang Wei
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

2.  Signatures of Mucosal Microbiome in Oral Squamous Cell Carcinoma Identified Using a Random Forest Model.

Authors:  Jianhua Zhou; Lili Wang; Rongtao Yuan; Xinjuan Yu; Zhenggang Chen; Fang Yang; Guirong Sun; Quanjiang Dong
Journal:  Cancer Manag Res       Date:  2020-07-03       Impact factor: 3.989

Review 3.  The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.

Authors:  Kosuke Mima; Keisuke Kosumi; Yoshifumi Baba; Tsuyoshi Hamada; Hideo Baba; Shuji Ogino
Journal:  Hum Genet       Date:  2020-11-12       Impact factor: 4.132

4.  The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies.

Authors:  Inge Huybrechts; Semi Zouiouich; Astrid Loobuyck; Zeger Vandenbulcke; Emily Vogtmann; Silvia Pisanu; Isabel Iguacel; Augustin Scalbert; Iciar Indave; Vitaly Smelov; Marc J Gunter; Nathalie Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

5.  Dysbiosis of the microbiome in gastric carcinogenesis.

Authors:  Natalia Castaño-Rodríguez; Khean-Lee Goh; Kwong Ming Fock; Hazel M Mitchell; Nadeem O Kaakoush
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

6.  Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients.

Authors:  Guoqin Yu; Javier Torres; Nan Hu; Rafael Medrano-Guzman; Roberto Herrera-Goepfert; Michael S Humphrys; Lemin Wang; Chaoyu Wang; Ti Ding; Jacques Ravel; Philip R Taylor; Christian C Abnet; Alisa M Goldstein
Journal:  Front Cell Infect Microbiol       Date:  2017-07-06       Impact factor: 5.293

7.  The gastric mucosal-associated microbiome in patients with gastric polyposis.

Authors:  Rongrong Ren; Zikai Wang; Huaibo Sun; Xuefeng Gao; Gang Sun; Lihua Peng; Bin Yan; Yunsheng Yang
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

Review 8.  Gastric microbiota: tracing the culprit.

Authors:  Cristian Vasile Petra; Aronel Rus; Dan Lucian Dumitraşcu
Journal:  Clujul Med       Date:  2017-10-20

Review 9.  The Role of Gastric Mucosal Immunity in Gastric Diseases.

Authors:  Siru Nie; Yuan Yuan
Journal:  J Immunol Res       Date:  2020-07-24       Impact factor: 4.818

10.  Optimized bacterial DNA isolation method for microbiome analysis of human tissues.

Authors:  Carlijn E Bruggeling; Daniel R Garza; Soumia Achouiti; Wouter Mes; Bas E Dutilh; Annemarie Boleij
Journal:  Microbiologyopen       Date:  2021-06       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.